Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-10

Clinical Trial Update: Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of fixed-dose combination tablets containing ezetimibe/rosuvastatin and candesartan cilexetil/amlodipine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ezetimibe/Rosuvastatin (ezetimibe/rosuvastatin)
  • candesartan cilexetil/amlodipine besylate (candesartan cilexetil/amlodipine besylate)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Hypertension, Hyperlipidemia | Phase 4 | Status: COMPLETED